Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

Fabio P. Nunes; Vanessa L. Merker; Dominique Jennings; Paul A. Caruso; Emmanuelle di Tomaso; Alona Muzikansky; Fred G. Barker II; Anat Stemmer-Rachamimov; Scott R. Plotkin

doi:10.1371/journal.pone.0059941

Loading metrics

Open Access

Peer-reviewed

Research Article

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

Fabio P. Nunes,

Affiliations Neurology Department, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Genetics Department, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Vanessa L. Merker,

Affiliations Neurology Department, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Stephen E. and Catherine Pappas Center for Neurooncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Dominique Jennings,

Affiliation A.A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Paul A. Caruso,

Affiliation Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Emmanuelle di Tomaso,

Affiliation Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Alona Muzikansky,

Affiliation Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Fred G. Barker II,

Affiliation Neurosurgical Service, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Anat Stemmer-Rachamimov,

Affiliation Pathology Department, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯
Scott R. Plotkin

* E-mail: splotkin@partners.org

Affiliations Neurology Department, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Stephen E. and Catherine Pappas Center for Neurooncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America
⨯

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

Fabio P. Nunes,
Vanessa L. Merker,
Dominique Jennings,
Paul A. Caruso,
Emmanuelle di Tomaso,
Alona Muzikansky,
Fred G. Barker II,
Anat Stemmer-Rachamimov,
Scott R. Plotkin

Published: March 21, 2013
https://doi.org/10.1371/journal.pone.0059941

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Meningioma
Is the Subject Area "Meningioma" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Neurofibromatosis type 2
Is the Subject Area "Neurofibromatosis type 2" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.